CEO: Peter Greenleaf
About Sucampo: Sucampo Pharmaceuticals, Inc. is focused on the development and commercialization of medicines that meet major unmet medical needs of patients worldwide. Sucampo has two marketed products – AMITIZA, its lead product, and RESCULA – and a pipeline of product candidates in clinical development. A global company, Sucampo is headquartered in Rockville, Maryland, and has operations in Japan, Switzerland and the U.K.
Why Rockville: At a time of rapid growth and advancement for Sucampo, we chose to make our home in Rockville, a central location in Maryland’s biotechnology corridor.